3-alpha-Hydroxysteroid Dehydrogenase (B-Specific): Clinical Trials

7 trials of 3-alpha-Hydroxysteroid Dehydrogenase (B-Specific), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 active not recruiting, 1 recruiting, 1 terminated. 4 Early Phase 1, 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Early Phase 14Completed 3, Terminated 1
Phase 13Active not recruiting 1, Completed 1, Recruiting 1
Phase 21Recruiting 1

Follow 3-alpha-Hydroxysteroid Dehydrogenase (B-Specific): new trials by email Literature Review of 3-alpha-Hydroxysteroid Dehydrogenase (B-Specific) trials Research Report on 3-alpha-Hydroxysteroid Dehydrogenase (B-Specific)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Multi-System Analysis of Opioid Receptor Binding
Carfentanil, C-11, Naloxone, Loperamide Hydrochloride - Healthy, Opioid Use Disorder
Phase 1Active not recruitingUniversity of Pennsylvania252022-09-202026-03-30
Study of Cardiac PET/CT Imaging to Guide Ablation Treatment of Ventricular Tachycardia
[C-11] Meta-hydroxyephedrine radioactive tracer (MHED) - Ventricular Tachycardia
Early Phase 1TerminatedKhaled Awad, MD112020-09-212024-12-24
[C-11]PiB PET Imaging in Alcohol Use Disorders
[C-11], Pittsburgh Compound B - Alcohol Use Disorder
Early Phase 1CompletedUniversity of Pittsburgh392018-12-012024-12-13
Multiparametric Imaging in Multiple Myeloma
C11 Methionine positron emission tomography - Multiple Myeloma
Phase 1CompletedYingbing Wang102016-07-012021-09-16
[C-11]NOP-1A and Alcohol Use Disorder
[C-11], NOP-1A - Alcohol Use Disorder
Early Phase 1CompletedRajesh Narendran542016-05-272022-07-11
PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Diseases
[F-18]PBR06, [C-11]PBR28 - Multiple Sclerosis, Alzheimer's Disease
Phase 1 / Phase 2RecruitingBrigham and Women's Hospital2502016-05-022026-01-28
[11C]NOP-1A and Cocaine Use Disorders
[C-11], NOP-1A - Cocaine Use Disorder
Early Phase 1CompletedUniversity of Pittsburgh492014-10-302019-08-05

Conditions studied

Alcoholism (2)  ·  Alzheimer Disease (1)  ·  Multiple Myeloma (1)  ·  Multiple Sclerosis (1)  ·  Opioid-Related Disorders (1)  ·  Tachycardia, Ventricular (1)

Sponsors

University of Pittsburgh (2)  ·  Brigham and Women's Hospital (1)  ·  Khaled Awad, MD (1)  ·  Rajesh Narendran (1)  ·  University of Pennsylvania (1)  ·  Yingbing Wang (1)

Countries

United States (7)

Top investigators

Tarun Singhal, MD (1)

Results publications

PMID 33934110, PMID 36382911, PMID 38630948, PMID 40341091

NIH funding

R01AA025247 (2), R01DA026472 (1)